On Nov, 25 2025, GSH Corporation (BDX) announced the deployment of proceeds from its recent subscription exercise and provided an updated summary of transactions with interested persons.

The company said that it raised net proceeds of 111.7 million Singapore dollars from the subscription, after about 0.2 million Singapore dollars of related expenses. As of Nov, 25 2025, 76.3 million Singapore dollars has been utilised: 75.8 million Singapore dollars was applied to repay new shareholders’ loans and 0.5 million Singapore dollars was used to settle other loans and borrowings. Management stated that these allocations align with the intended uses outlined in an earlier circular.

GSH also updated the value of interested person transactions for the financial year ending Dec, 31 2025. Total aggregated financing costs involving Dr. Sam Goi and his associates amount to 6.838 million Singapore dollars, equal to 1.93% of the group’s net tangible assets of 354.097 million Singapore dollars as at Dec, 31 2024. This comprises: • 3.198 million Singapore dollars in financing costs from shareholders’ loans (0.90% of NTA) • 3.640 million Singapore dollars in costs related to the subscription (1.03% of NTA) Financing costs tied to the previously undertaken 2025 convertible bonds are now nil following the cancellation of the proposed rights issue.

The announcement was issued by CEO and Executive Director Gilbert Ee Guan Hui.